Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?

The fourth-quarter 2024 reporting cycle of the Medical sector is in full swing. The sector primarily comprises pharma/biotech and medical device companies.See the Zacks Earnings Calendar to stay ahead of market-making news.The earnings season for the medical sector kicked off late last month when pharma giant J&J reported fourth-quarter earnings. Though J&J’s earnings and sales beat estimates, its 2025 sales guidance fell below expectations. Last week, several pharma big-wigs like AbbVie, Novartis, Roche an ...